Literature DB >> 17622105

Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology.

Yogesh Rane1, Rajshree Mashru, Mayur Sankalia, Jolly Sankalia.   

Abstract

The objective of this work was to study dissolution enhancement efficiency and solid dispersion formation ability of hydrophilic swellable polymers such as sodium carboxymethyl cellulose (Na-CMC), sodium starch glycolate (SSG), pregelatinized starch (PGS), and hydroxypropylmethyl cellulose (HPMC) with carbamazepine using 3(2) full factorial design for each of the polymers. Solid dispersions of carbamazepine were prepared using solvent evaporation method with around 70% solvent recovery. The independent variables were the amount of polymer and organic solvent. The dependent variables assessed were percentage drug dissolved at various time points and dispersion efficiency (ie, in terms of particle size of solid dispersion). Solid dispersions were evaluated for percentage drug dissolved, wettability, differential scanning calorimetry, scanning electron microscopy, and angle of repose. Multiple linear regression of results obtained led to equations, which generated contour plots to relate the dependent variables. Similarity factor and mean dissolution time were used to compare dissolution patterns obtained in distilled water and simulated gastric fluid United States Pharmacopeia (USP) XXVI of pH 1.2. Maximum drug dissolution was obtained with polymer order Na-CMC>SSG>PGS>HPMC. Particle size of drug was reduced ~10-15, 3-5, 5-7, and 10-25 times in Na-CMC, SSG, PGS, and HPMC solid dispersions, respectively; whereas wettability of solid dispersions was found in the order of Na-CMC>HPMC>PGS>SSG. Angle of repose was found to be in the range of 29 degrees to 35 degrees for all solid dispersions, which shows good flowability characteristics. HPMC showed increase in drug dissolution up to an optimized level; however, further increase in its concentration decreased drug dissolution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622105      PMCID: PMC2750367          DOI: 10.1208/pt0802027

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  26 in total

Review 1.  Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards.

Authors:  R Löbenberg; G L Amidon
Journal:  Eur J Pharm Biopharm       Date:  2000-07       Impact factor: 5.571

Review 2.  Improving drug solubility for oral delivery using solid dispersions.

Authors:  C Leuner; J Dressman
Journal:  Eur J Pharm Biopharm       Date:  2000-07       Impact factor: 5.571

3.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

4.  Powdered solution technology: principles and mechanism.

Authors:  S S Spireas; C I Jarowski; B D Rohera
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

5.  Development and evaluation of fast-dissolving film of salbutamol sulphate.

Authors:  R C Mashru; V B Sutariya; M G Sankalia; P P Parikh
Journal:  Drug Dev Ind Pharm       Date:  2005-01       Impact factor: 3.225

6.  The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.

Authors:  Ali Nokhodchi; Yousef Javadzadeh; Mohammad Reza Siahi-Shadbad; Mohammad Barzegar-Jalali
Journal:  J Pharm Pharm Sci       Date:  2005-01-12       Impact factor: 2.327

7.  Dissolution properties and in vivo behaviour of triamterene in solid dispersions with polyethylene glycols.

Authors:  M J Arias; J M Ginés; J R Moyano; A M Rabasco
Journal:  Pharm Acta Helv       Date:  1996-10

Review 8.  The current status of solid dispersions.

Authors:  J L Ford
Journal:  Pharm Acta Helv       Date:  1986

9.  Enhancement of dissolution rate of piroxicam using liquisolid compacts.

Authors:  Y Javadzadeh; M R Siahi-Shadbad; M Barzegar-Jalali; A Nokhodchi
Journal:  Farmaco       Date:  2005-04

10.  Solubilization and wetting effects of bile salts on the dissolution of steroids.

Authors:  V Bakatselou; R C Oppenheim; J B Dressman
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

View more
  7 in total

1.  Dissolution and solid-state characterization of poorly water-soluble drugs in the presence of a hydrophilic carrier.

Authors:  Rahmat Talukder; Chase Reed; Thomas Dürig; Muhammad Hussain
Journal:  AAPS PharmSciTech       Date:  2011-09-20       Impact factor: 3.246

2.  Development, optimization, and anti-diabetic activity of gliclazide-loaded alginate-methyl cellulose mucoadhesive microcapsules.

Authors:  Dilipkumar Pal; Amit Kumar Nayak
Journal:  AAPS PharmSciTech       Date:  2011-10-25       Impact factor: 3.246

3.  Effects of commonly used excipients on the expression of CYP3A4 in colon and liver cells.

Authors:  Leslie Tompkins; Caitlin Lynch; Sam Haidar; James Polli; Hongbing Wang
Journal:  Pharm Res       Date:  2010-05-26       Impact factor: 4.200

4.  Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking.

Authors:  Punit P Shah; Rajashree C Mashru; Yogesh M Rane; Arti Thakkar
Journal:  AAPS PharmSciTech       Date:  2008-02-20       Impact factor: 3.246

5.  Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques.

Authors:  Manjil Patel; Avinash Tekade; Surendra Gattani; Sanjay Surana
Journal:  AAPS PharmSciTech       Date:  2008-12-31       Impact factor: 3.246

6.  Improved dissolution of Kaempferia parviflora extract for oral administration by preparing solid dispersion via solvent evaporation.

Authors:  Yotsanan Weerapol; Sukannika Tubtimsri; Chaweewan Jansakul; Pornsak Sriamornsak
Journal:  Asian J Pharm Sci       Date:  2016-11-04       Impact factor: 6.598

7.  Characterization of olanzapine-solid dispersions.

Authors:  Venkateskumar Krishnamoorthy; Arunkumar Nagalingam; Verma Priya Ranjan Prasad; Siva Parameshwaran; Neema George; Punitha Kaliyan
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.